Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

July 19, 2017August 29, 2017

Scientists Study How Abivax’s Anti-Inflammatory Product ABX464 Works in IBD

Crohn's Disease, News

Researchers have gained new insights into how Abivax’s investigational product ABX464 works. The therapy is currently under investigation in Phase 2 trials in patients with inflammatory bowel disease (IBD). Findings of ... Read more

July 5, 2017July 5, 2017

Loss of NLRX1 Gene May Contribute to Bowel Disease Development, Study Shows

News

A gene called NLRX1 plays a crucial role in inhibiting the abnormal immune system response to gastrointestinal inflammation that occurs in bowel disease, according to a study. Loss of the gene ... Read more

June 28, 2017

Researchers Identify Fungus That May Worsen Crohn’s Disease Symptoms

News

The fungus Candida tropicalis may trigger gut inflammation and worsen Crohn’s disease, according to results of a study presented at this year’s Digestive Disease Week, held recently in Chicago. The ... Read more

June 27, 2017

Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease

News

Treatment has been completed in a Phase 2 clinical trial of brilacidin for ulcerative proctitis and ulcerative proctosigmoiditis — a study that led to six of the 12 patients’ bowel ... Read more

May 24, 2017

Miraca’s InformTx Treatment Response Platform for IBD Now Includes Testing for Inflectra

News

Miraca Life Sciences‘ InformTx testing helps doctors assess the response of patients with inflammatory bowel disease (IBD) to certain drug treatments. The company has now expanded its therapeutic drug monitoring ... Read more

May 23, 2017May 23, 2017

Shire’s SHP647 Shows Promise as Potential Ulcerative Colitis Treatment, Study Finds

News

Treatment with SHP647 (also known as PF-00547659) significantly decreased remission rates in a Phase 2 clinical trial of patients with ulcerative colitis, a type of inflammatory bowel disease (IBD). The ... Read more

April 26, 2017April 26, 2017

Mutations in INAVA Gene May Increase Risk of IBD, Yale Study Shows

News

Mutations of the INAVA gene may boost the risk of inflammatory bowel disease (IBD), according to a new study whose findings not only explain the pathological mechanisms underlying IBD, but may also help design new ... Read more

March 21, 2017March 21, 2017

Arizona State, Mayo Clinic Researchers Identify Potential New Biomarkers for Diagnosing Crohn’s

News

Researchers have identified novel biomarkers for diagnosing Crohn’s disease in a collaborative study between Arizona State University’s Biodesign Institute and the Mayo Clinic. They also built a novel blood test that distinguishes ... Read more

February 17, 2017

Changes in T-bet Proteins May Predispose Individuals For IBD, Study Says

News

Genetic variations affecting a protein called T-bet may predispose individuals to inflammatory bowel disease (IBD), according to a study. This finding may contribute to the development of novel treatments for ... Read more

January 26, 2017

Protein, SCIMP, Identified as Trigger in Inflammation, Could be Target of Treatments

News

Researchers have identified a protein — SCIMP — as a molecular trigger for inflammation, according to a new study. The information could be useful in developing treatments for conditions such as ... Read more